pharma news today glp-1 obesity Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat and other weight-related conditions Patient Behavior: How Does Price

Oct 20: Nearly two years ago, the FDA approved BioMarins Voxzogo (vosoritide) as the first therapy for achondroplasia, a rare genetic disorder that causes the most common form of dwarfismfueling ongoing controversy within the dwarfism community about such treatments

This hormone shows effects on metabolism, endocrine system, immunity and energy balance

Can genetic testing help predict my risk of yeast infections on GLP-1 therapy

Earlier this year Trulicity was approved by the FDA to reduce the risk of stroke and heart attack for adults with type 2 diabetes and pre-existing heart disease, or at risk for heart disease

Provider-led, personalized approach Clinicians create a personalized treatment plan based on your goals, needs, and medical history

Midlife isnt the time to white-knuckle it or blame yourself for body changes